Christopher F. Davis
Research analyst, REITs, biotech, small-cap

Response Genetics: Moving In The Right Direction And The Stock Should Follow Suit

When looking for a potentially undervalued stock, there are many methods that one can utilize. In this article, I will cover Response Genetics (NASDAQ:RGDX). The way in which I have identified this stock as potentially undervalued is certainly not perfect, but can definitely point the needle in the direction that a company's stock should move. The first thing I am looking for is recent price action. Has the stock been on a tear that is warranted? Is it rising but just on speculation and likely to crater? Is the stock dropping and if so, is it warranted, or is it overblown? Next I look to the company's most recent quarterly performance. How is the year-over-year change? Is...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details